LORD is collaborating on two main axis which are the Concept Studies and EMS Specification and the second which is Innovation and New Technology Development.
During the first period, the consortium led by LORD has been working on Management and Reporting and EMS for Ground Test (GT) Design and Development as well as identifying preliminary instrumentation needs related to Support activities for the Engine GT. The Management and reporting activities have mainly been impacted by several schedule changes communicated by the Topic Manager and the consequent changes to milestone, deliverables, and work packages description of the Consortium DOA.
Some preliminary activities within the GT Design and Development have been performed to support the different iterations of engine and installation configuration from the Topic Manager.
During the second period, the consortium has been working on WP1 (management), WP2 (system dynamic model), WP3 (design & dev.) and WP7 (Innovation).
Within WP1, the consortium has organized specific sessions with the Consortium to reinforce internal procedures supporting the project management and also covering the requirements for technical and financial reporting.
For WP2, the Topic Manager delivery was on March 2018 and resulted in discussion to define and commonly agree on a path forward.
In WP3 there were no actual deliverables due during the second period. A schedule push out was announced by the Topic Manager in October 2017. The consortium did nonetheless pursue some activities that have been executed to consolidate the up to date EMS design.
Within WP7, we have continued to investigate and work on Advanced Manufacturing Methods and technologies with the aim to reduce manufacturing lead-time, complexity and costs; looking into manufacturing processes and methods developing new solutions and technologies that are intended to address the challenges coming from the new generation turbofan engines.
During the third period, the consortium has been working on WP1, WP2, WP3, WP4 (manufacturing) and WP7. WP1 activities were in line with the GA in Force. WP2 and WP7 activities have been impacted by issues related on consortium modelling needs as expressed in DOA, against the Topic Manager modelling delivery. In order to accommodate these, the consortium worked during this third period on a plan that intended to have a better overall visibility on the critical path (WP3 & 4) when the Topic Manager will kick-off again these activities, as well as, continuing to set-up partnership, create detailed statement of works and develop low TRL technologies from WP7.
During the fourth period, the consortium has been working on WP1, WP2 and WP7. WP1 activities were still mainly impacted by the last UHPE schedule communicated by the Topic Manager on June 06, 2019 that directly affects the consortium WP3, 4, 5 & 6. WP2 being impacted by issues related on consortium modelling needs as expressed in DOA, against the Topic Manager modelling delivery (cf Third Period), activity on this Work Package were dedicated to support the Deliverable D2.1. Some low TRL technologies from WP7 being also impacted by issues related on consortium modelling needs (cf Third Period), the consortium dedicated its effort on WP7 technologies development that aren’t dependant on specific inputs from the Topic Manager.
During the fifth period, consortium main activities were focused on:
- WP1: GA Amendment (not impacted by COVID-19 situation)
- WP7: Highly impacted by COVID-19 situation.
Simulation and experimental activities are tightly integrated, thus the development of simulation tools was slowed because of the lack correlation with experimental data.
The sixth reporting period has been impacted by the second wave of COVID-19 pandemic.
During this sixth period, consortium main activities were focused on:
- WP1: Final discussion and encoding of GA Amendment
- WP3: Design activities related to the WP5 prototypes and deliverable D3.3
- WP5: Deliverable D5.1 testing specification to support the low TRL implementation on EMS components
- WP7: Highly impacted by COVID-19 situation.
As for the previous reporting period, simulation and experimental activities are tightly integrated; thus the development of simulation tools was slowed because of the lack correlation with experimental data.
As a result of the pandemic situation:
• Prioritization on activities that are not impacted by COVID19 lockdown such as modelling activities, with limitation to the fact that modelling activities needs testing input (all testing facilities being under lockdown)
• Consider in the amendment effort that was under discussion prior the pandemic, a new timeline which takes into account a total of 10 months delay due to first and second wave of COVID-19, bringing the project end to December 2022.
To conclude, HEGGEMANN termination process was still ongoing during the sixth period.
The seventh period has also been impacted by the COVID-19 pandemic, from manpower, travel, and supply chain standpoints.
During this last period, consortium main activities were focused on:
- WP1: Management and reporting; Deliverable D1.2
- WP3: Design and development activities related to the WP5 prototypes
- WP4: Manufacturing and Delivery; Deliverable D4.1
- WP5: Testing; Deliverable D5.1 & Deliverable D5.2
- WP7: Innovation and new technologies development, Deliverable D7.2 Milestones M3 & M8
At project completion, the WP7 technologies implemented in WP3, 4 & 5 have seen their TRL increased to a maximum of TRL4-5.
From a communication and dissemination stand point, this project has contributed to:
- 1 PhD and 3 MS thesis
- 5 Journal papers, 2 Conference proceedings
- A paper makes available raw measurements by means of an open access database
- 8 dedicated web pages, 1 Tweet, 2 Linkedin announcement
- 1 joint patent
